Acrylic nanoparticles for ocular drug delivery

S.T.P. Pharma Sciences

Volumn 7, Issue 6, 1997, Pages 445-451

  Langer, K ^a   Zimmer, A ^a   Kreuter, J ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Acrylic nanoparticles; Ocular drug delivery Pilocarpine

Indexed keywords

ACECLIDINE; AMIKACIN; ARECAIDINE; BETAXOLOL; CYANOACRYLATE; METHACRYLIC ACID; METIPRANOLOL; NANOPARTICLE; PILOCARPINE; POLY(METHYL METHACRYLATE); PROGESTERONE; TIMOLOL;

DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; GLAUCOMA; PARTICLE SIZE; REVIEW; VISCOSITY;

EID: 0031544662     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. PATTON T.F, and ROBINSON J.R. Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes, J. Pharm. Sei., 65, 1295-1301, 1976.
2. LEE V. H.L. and ROBINSON J.R. Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits. J. Pharm. Sei., 68, 322-333, 1979.
3. KREUTERJ.-Particulates(nanoparticlesandmicroparticles). In : Ophthalmic drug delivery systems, A. K. Mitra Ed., Marcel Dekker, New York, 1993, pp. 275-285.
4. PEPPAS N.A. and BURI P.A. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J. Controlled Pel., 257-275, 1985.
5. PIMENTA C., LENAERTS V., CADIEUX C., RAYMOND P., JUHASZ J., SIMARD M.A. and JOLICEUR C. Mucoadhesion of hydroxypropyl methacrylate nanoparticles to intestinal ileal segments in vitro. Pharm. Res., 7,49 - 53.1990.
6. UNLÜ N., LUDWIG A., VAN OOTEGHEM M. and HINCAL A.A. Formulation of Carbopol 940 ophthalmic vehicles, and in vitro evaluation of the influence of stimulated lacrirnal fluid on their physicochemical properties. Pharmazie, 46, 784-788, 1991.
7. GURNY R., IBRAHIM H., AEBI A., BURI P., WILSON G.G., WASHINGTON N., EDMAN P. and CAMBER O. - Design and evaluation of controlled release systems for the eye. - J. Controlled Rel., 367-373,1987.
8. KREUTER J. Nanoparticles. In : Encyclopedia of Pharmaceutical Technology, J.S. Boylanand J.C. Boylan Eds., Marcel Dekker, New York, 1994, pp. 165-190.
9. KREUTER J. and ZEHNDER H.J. The use of 60Co-y-irradiation for the production of vaccines. Radiation Effects, 35,161-166, 1978.
10. BERG U.E., KREUTER J., SPEISER P.P and SOLVIA M. Herstellung und /n-w'fro-Prüfung von polymerenAdjuvantien für Impfstoffe. Pharm. Ind., 48, 75-79, 1986.
11. ROLLAND A., GIBASSIER D., SADO P. and LE VERGE R. Méthodologie de préparation de vecteurs nanoparticulaires à base de polymères acryliques. J. Pharm. Belg., 41, 83-93, 1986.
12. KREUTER J., LIEHL E., BERG U., SOLVIA M. and SPEISER P.P. Influence of hydrophobicity on the adjuvant effect of particulate polymeric adjuvants. Vaccine, 6, 253-256,1988.
13. ZOSEL B., KUNZE H. and DITTGEN M. Einflu der lonenstärke auf das Zetapotential von Polyacrylatlatices. Pharmazie, 43, 653-654, 1988.
14. DITTGEN M. and ZOSEL B. Influence of valence and concentration of electrolytes on the zeta potential of polyacrylic lattices. Colloid Polym. Sei., 269, 259-263, 1991.
15. LUKOWSKI G., MÜLLER R.H., MÜLLER B.W. and DITTGEN M. Acrylic acid copolymer nanoparticles for drug delivery. I : Characterization of the surface properties relevant for in vivo organ distribution. Int. J. Pharm., 84, 23-31,1992.
16. LANGER K., MARBURGER C., BERTHOLD A., KREUTER J. and STIENEKER F. Methyl methacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery. I : Preparation and physicochemical characterization. Int, J. Pharm., 137, 87-74,1996.
17. WOOD R.W., LI V. H.K., KREUTER J. and ROBINSON J.R. Ocular disposition of polyhexyl-2-cyano[3-C] acrylate nanopartiofea in albino rabbits. - Int. J. Pharm., 23, 175-163, 1985.
18. KREUTER J. Nanoparticlesas bioaclhesiveoculardrug deliver/ systems. In : Bioadhesive Drug Defivery Systems, V. Lenaerts and R. Gurny Eds., CRS Press, Boca Raton, 1990, pp. 203212.
19. FITZGERALD P., HADGRAFT J., KREUTER J. and WILSON G.G.- A Y-scintigraphic evaluation of microparticulate ophthalmic delivery systems : liposomes and nanoparticles - Int. J. Pharm., 40,81-84, 1987.
20. VEZIN W. R. and FLORENCE A.T. In vitro degradation rates of biodegradable poly-n-alkyl cyanoacrylates. J. Pharm. Pharmacol., 30, 5P, 1978.
21. VEZIN W.R. and FLORENCE A.T. In vitro heterogeneous degradation of poly(n-alkyl a-cyanoacrylates). J. Biomed. Mater. Res., 14, 93-106,1980.
22. STEIN M. and HAMACHER E. Degradation of polybutyl 2cyanoacrylate microparticles. Int. J. Pharm., 80, R11-R13, 1992.
23. DIEPOLD R., KREUTER J., GUGGENBUHLP. and ROBINSON J.R. Distribution of poly-hexyl-2-cyano[3-14C] acrylate nanoparticles in healthy and chronically inflamed rabbit eyes. Int. J. Pharm., 54, 149-153, 1989.
24. ZIMMER A.K., MAINCENT P., THOUVENOT P. and KREUTER J. Hydrocortisone delivery to healthy and inflamed eyes using a rnicellar polysorbate 80 solution or albumin nanoparticles. Int. J. Pharm., 110,211-222, 1994.
25. ZIMMER A., KREUTER J. and ROBINSON J.R.-Studies on the transport pathway of PBCA nanoparticles in ocular tissues. J. Microencapsulation, 8, 497-504,1991.
26. KAYE G.I. and PAPPAS G.D. - Studies on the cornea. I : The fine structure of the rabbit cornea and the uptake of colloidal particles by the cornea. - J. Cell. Biol., 12,157-179,1962.
27. SIEG J.W. and TRIPLET! J.W. Precorneal retention of topical instilled micronized particles. J. Pharm. Soi., 69, 863-864, 1980.
28. HARMIA T., SPEISER P. and KREUTER J. Optimization of pilocarpine loading onto nanoparticles by sorption procedures. Int. J. Pharm., 33, 45-54, 1986.
29. HARMIA T., SPEISER P. and KREUTER J. A solid colloidal drug delivery system for the eye : encapsulation of pilocarpine in nanoparticles. J. Microencapsulation, 3, 3-12,1986.
30. HARMIA T., KREUTER J., SPEISER P., BOYE T., GURNY R. and KUBIS A. Enhancement of the myotic response of rabbits with pilocarpine-loaded polybutyl cyanoacrylate nanoparticles. Int. J. Pharm., 33, 187-193, 1986.
31. HARMIA-PULKKINEN T., TUOMI A. and KRISTOFFERSSON E. Manufacture of polyalkyl cyanoacrylate nanoparticles with pilocarpine and timolol by micelle polymerization : factors influencing particle formation. J. Microencapsulation, 6,87-93, 1989.
32. DIEPOLD R., KREUTER J., HIMBER J., GURNY R., LEE V.H.L, ROBINSON J.R., SAETTONE M.F. and SCHNAUDIGEL O.E.-Comparison of different models forthe testing of pilocarpine eyedrops using conventional eyedrops and a novel depot formulation (nanoparticles). Graefe's Arch. Clin. Exp. Ophthalmol., 227, 188-193, 1989.
33. ZIMMER A., MUTSCHLER E LAMBRECHT G., MAYER D. and KREUTER J. Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle delivery system. Pharm. Res., 11, 1435-1442, 1994.
34. MARCHAL-HEUSSLER L, MAINCENT P., HUFFMAN M., SPITTLER J. and COUVREUR P. Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutyl cyanoacrylate nanoparticle preparations. Int. J. Pharm., 58, 115-122, 1990.
35. MARCHAL-HEUSSLER L, FESSI H., DEVISSAGUET J.P., HUFFMAN M. and MAINCENT P. Colloidal drug delivery systems for the eye. A comparison of the efficacy of three different polymers : polisobutyl cyanoacrylate, polylactic-coglycolic acid, poly-e-caprolactone. S.T.P. Pharma Sei., 2, 98105, 1992.
36. AI-KHOURI N., ROBLOT-TREUPEL L., FESSI H., DEVISSAGUET J.P. and PUISIEUX F.-Development of anew process for the manufacture of polyisobutyl cyanoacrylate nanocapsules. Int. J. Pharnnacol., 28, 125-132, 1985.
37. LOSAC., MARCHAL-HEUSSLER L, ORALLO F., VILAJATO J. L. and ALONSO M. J. Design of new formulations for topical ocular administration : polymeric nanocapsules containing metipranolol. Pharm. Res., 10, 80-87, 1993.
38. LOSAC.,CALVOP.,CASTROE.,VILA-JATOJ.L.andALONSO M.J. Improvement of ocular penetration of amikacin sulphate by association to polybutyl cyanoacrylate nanoparticles. J. Pharm. Pharmacol., 43, 548-552, 1991.
39. LI V.H.K., WOOD R.W., KREUTER J., HARMIA T. and ROBINSON J.R. Ocular drug delivery of progesterone using nanoparticles. J. Microencapsulation, 3, 213-218, 1986.
40. LANGER K. - Entwicklung und Charakterisierung kolloidaler Systeme als Träger für Muscarinrezeptor-Agonisten zur Anwendung am Auge. - Verlag Shaker, Aachen, 1997.
41. ZIMMER A.K., CHETONI P., SAETTONE M.F., ZERBE H. and KREUTER J. Evaluation of pilocarpine-loaded albumin particles as controlled drug delivery systems for the eye. II : Coadministration with bioadhesive and viscous polymers. J. Controlled Rel., 33, 31-46, 1995.